SciCombinator

Discover the most talked about and latest scientific content & concepts.

MC Lu, JA Ji, YL Jiang, ZY Chen, ZW Yuan, QD You and ZY Jiang
Abstract
Ulcerative colitis (UC) is a chronic relapsing-remitting form of inflammatory bowel disease (IBD) that increases the risk of colorectal cancer, the third most common malignancy in humans. Oxidative stress is a risk factor for the development of UC. The Keap1-Nrf2-ARE pathway is one of the most important defensive mechanisms against oxidative and/or electrophilic stresses. In this study, we identified CPUY192018 as a potent small-molecule inhibitor of the Keap1-Nrf2 PPI, investigated the cyto-protective effects of CPUY192018 on the NCM460 colonic cells and evaluated whether treatment with the inhibitor of the Keap1-Nrf2 PPI exerts protection on an established experimental model of UC induced by dextran sodium sulfate (DSS). Our study clearly demonstrated that CPUY192018 had a cytoprotective effect against DSS in both NCM460 cells and mouse colon via the activation of Nrf2 signaling. These results suggested that activation of Nrf2 by directly inhibiting the Keap1-Nrf2 PPI may be beneficial as a treatment for UC.
Tweets*
0
Facebook likes*
1
Reddit*
0
News coverage*
0
Blogs*
0
SC clicks
2
Concepts
Large intestine, Toxic megacolon, Ileostomy, Cancer, Inflammatory bowel disease, Crohn's disease, Colon, Ulcerative colitis
MeSH headings
-
comments powered by Disqus

* Data courtesy of Altmetric.com